Rituximab for Autoimmune Retinopathy

NCT01086631 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Autoimmune Disease

Interventions

DRUG: Rituximab

Sponsor

National Eye Institute (NEI)